Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.07.04.20142752: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Sample collection: Written informed consent for all individuals in this study was provided in compliance with an institutional review board protocol.
IRB: Sample collection: Written informed consent for all individuals in this study was provided in compliance with an institutional review board protocol.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Healthy volunteers were age-matched to the extent possible, including a 3 year-old female, 6 year-old female, 7 year old male, 12 year-old male, and 19 year-old female. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources To … SciScore for 10.1101/2020.07.04.20142752: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Sample collection: Written informed consent for all individuals in this study was provided in compliance with an institutional review board protocol.
IRB: Sample collection: Written informed consent for all individuals in this study was provided in compliance with an institutional review board protocol.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Healthy volunteers were age-matched to the extent possible, including a 3 year-old female, 6 year-old female, 7 year old male, 12 year-old male, and 19 year-old female. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources To assess the distribution of different immunoglobulin isotypes, assays were performed separately with anti-human IgA-AP antibody, anti-human IgM-AP antibody, anti-human IgG1 Fc-AP, anti-human IgG2 Fc-AP, anti-human IgG3 hinge-AP and anti-human IgG4 Fc-AP. anti-human IgG4suggested: NoneFollowing fixation, the cells were washed, permeabilized with 0.1% Triton X-100, blocked in a 3% milk solution (American Bio) and stained with a monoclonal antibody to anti-SARS nucleoprotein (Amanat 2020) and subsequently a goat anti-mouse IgG–HRP (Rockland Immunochemicals). anti-SARS nucleoproteinsuggested: Nonea goat anti-mouse IgG–HRP (Rockland Immunochemicals)suggested: Noneanti-mouse IgG–HRPsuggested: NoneExperimental Models: Cell Lines Sentences Resources This virus–serum mixture was then added to Vero E6 cells (ATCC) plated in a 96-well cell culture plate and incubated at 37 °C for 1 hour. Vero E6suggested: NoneSoftware and Algorithms Sentences Resources FCS files were analyzed using Cytobank. Cytobanksuggested: (Cytobank, RRID:SCR_014043)Quantile normalized matrices were read into R statistical environment (4.0.1) and analyzed using the DESeq2 and limma R packages. DESeq2suggested: (DESeq, RRID:SCR_000154)limmasuggested: (LIMMA, RRID:SCR_010943)Overlap of enriched samples were visualized by the UpSetR package and tile plot and heat map visualizations were drawn by the ggplot2 software. ggplot2suggested: (ggplot2, RRID:SCR_014601)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-